[go: up one dir, main page]
Cart 0
Cart 0
Now offering solutions in animal health as Amend Pet
visit Amend Pet
Tend and Amend Pet make it easier to access, understand, and use the gut microbiome for a healthier world, inside and out.
Our work in human medicine
The microbiome—often called our “second brain”—affects nearly every process and system in the body. And when it’s disrupted, it has a serious impact on our health.
THE REALITY

Common medical treatments like antibiotics and chemotherapy can disrupt the gut microbiome with a single dose.

This makes us more susceptible to serious health conditions, including infectious diseases.

THE PROBLEM WITH THE SOLUTION

The diverse gut microbiome from a healthy individual’s stool is used as a proven therapeutic. Unfortunately, processing a stool sample into oral capsules for therapeutic use is difficult, and the alternatives are invasive and expensive.

Introducing TendThe health company that is making it radically easier for researchers, clinicians, and patients to access and understand the natural healing superpower of the gut microbiome.
 
 
the device that (simply) changes everythingClean. Simple. Encapsulated.Easily collect, prepare, and encapsulate the gut microbiome material in stool for approved therapeutic use.
Watch how it works ▶
 Helping people heal from within—at a fraction of the time, cost, and effort.

Through improved access

Tend’s Collection and Processing (CAP) Device

The rapid, reliable, and remarkably easy way to collect and prepare the microbiome material in stool for therapeutic use.

HOW THE DEVICE WORKS
When it comes to harnessing the potential of the gut microbiome, we have work to do. And we need your help.

We founded Tend to make it easier for researchers and clinicians to do the important work of treating patients today while also expanding the impact of the gut microbiome for patient healing tomorrow.

Interested in a better processing device for the gut microbiome for your patients, research, or clinical trial? We’d love to collaborate!

partner with us
 
EJR61456.jpg
Latest postsMainstreaming the MicrobiomeWe happily publish and share relevant resources that give “the scoop on poop” and other news from around the fascinating world of the gut microbiome.

This information is not medical advice.
It is a collection of ideas and information about the emerging world of research, clinical trials, and news related to Tend and the gut microbiome.

Featured Posts
What is a “healthy” microbiome? Is there such a thing? And why does it matter?
What is a “healthy” microbiome? Is there such a thing? And why does it matter?

Before we can mainstream microbiome-based treatments, we need to establish a baseline understanding of what constitutes a “healthy microbiome”. Tend Chief Scientific Officer Will DePaolo explains why that’s a lot harder than it sounds and what can be done.

Read More →
The secret to good health later in life? Researchers think it could be banking your poop now
The secret to good health later in life? Researchers think it could be banking your poop now

Researchers discuss the potential for banking an individual’s microbiome when they’re healthy, for future use when they’re not.

Read More →
Will Explains: Introduction to the Microbiome
Will Explains: Introduction to the Microbiome

Taking care of our gut microbiome starts with understanding it - here’s a 101 short course from Tend Chief Scientific Officer Will DePaolo.

Read More →
Capsules or Colonoscopies? today’s Reality and Tomorrow’s Potential
Capsules or Colonoscopies? today’s Reality and Tomorrow’s Potential

Tend CMO Tom Lendvay talks about the advantages to patients and clinicians of Capsules over Colonoscopies for administering FMT. And looks ahead to what gets better as the Capsule method gets more traction.

Read More →
Getting to know our new CEO
Getting to know our new CEO

New Tend CEO Mike Goonewardene shares a bit about what caught his eye with Tend, what the road ahead looks like and how his professional (and personal) travels led him here.

Read More →
FMT FAQs: Tom Lendvay Talks Poop, Process, and Potential
FMT FAQs: Tom Lendvay Talks Poop, Process, and Potential

We see all this evidence and discussion about FMT and its efficacy for treating Clostridium difficile (C. diff.). If it’s proven so effective, why isn’t it happening more?

Read More →

DISCLAIMER

Patent Pending. Tend’s Gut Microbiome CAP device is not yet commercially available. While FMT is regulated by the FDA for the treatment of recurrent Clostridium difficile infection (C. diff.), the device has not been evaluated by the Food and Drug Administration. At this stage, the CAP device is only available for clinical trials and research. This product is not intended to diagnose, treat, cure, or prevent any disease, injury or condition. The CAP device is only intended to mix, filter and encapsulate a stool sample.